Browsing Category
Healthcare Industry News
2469 posts
FDA clears Hyperfine’s Optive AI update as Swoop system adds advanced diffusion imaging for stroke care
Find out how FDA clearance of Hyperfine’s Optive AI update enhances stroke detection and strengthens the Swoop portable MRI platform.
Philips strengthens image-guided therapy portfolio with SpectraWAVE deal focused on AI coronary assessment
Find out how Royal Philips’ SpectraWAVE acquisition strengthens AI-driven coronary imaging and reshapes image-guided therapy in cardiology.
RemeOs DrillPin designation boosts Bioretec’s U.S. regulatory momentum in bioresorbable implants
Find out how Bioretec’s FDA Breakthrough Device Designation for its RemeOs DrillPin may reshape U.S. orthopedic fracture care and support its strategic ambitions.
At-home 12-lead ECG now a reality after FDA greenlights HeartBeam’s cable-free technology
Discover how HeartBeam’s FDA-cleared cable-free 12-lead ECG brings hospital-grade heart monitoring into homes and what it means for patients and investors.
Largest real-world study validates Lucid Diagnostics’ swallow-based test for early esophageal precancer detection
Find out how Lucid Diagnostics’ largest real-world study validates its swallow-based esophageal precancer screening technology and reshapes early detection.
Why Alcon raised its bid for STAAR Surgical and dropped matching rights in amended merger deal
Find out how Alcon raised its cash bid for STAAR Surgical and removed matching rights to secure a $1.6 billion refractive-technology acquisition.
ResMed advances AI sleep therapy strategy with FDA clearance of Smart Comfort for CPAP users
Discover how ResMed’s FDA-cleared Smart Comfort uses AI to personalize CPAP therapy and what this milestone means for sleep apnea care and investors.
Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening?
Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story.
Why ALR Technologies is betting big on pet CGMs with its GluCurve relaunch in 2026
Find out how ALR Technologies’ GluCurve Pet CGM aims to transform diabetic pet care as it relaunches in Canada—read the full story for key milestones.
Respiree’s AI-enabled 1Bio software gets HSA greenlight for acute deterioration detection
Respiree’s AI-powered 1Bio AI-Acute gets HSA approval in Singapore for detecting acute deterioration. Find out what’s next in its global expansion push.